Industry Research Reports

Home > Reports > Chemical & Material > Global Milbemycin Oxime API Market Research Report 2025

Global Milbemycin Oxime API Market Research Report 2025

Industry: Chemical & Material

Published: 2025-01-07

Pages: 78 Pages

Report ld: 3524854

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Milbemycin Oxime API was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite"s nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime API.

The Milbemycin Oxime API market size, estimations, and forecasts are provided in terms of output/shipments (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Milbemycin Oxime API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Milbemycin Oxime API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Milbemycin Oxime API Market Research Report 2025
Global Milbemycin Oxime API Companies Covered
Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd, JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Global Milbemycin Oxime API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Milbemycin Oxime API Market, Segment by Type
98% Purity

Purity Greater than 98%
Global Milbemycin Oxime API Market, Segment by Application
Dog

Cat

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Milbemycin Oxime API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Milbemycin Oxime API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Table of Contents

 1 Milbemycin Oxime API Market Overview
    1.1 Product Definition
    1.2 Milbemycin Oxime API by Type
        1.2.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Type: 2024 VS 2031
        1.2.2 98% Purity
        1.2.3 Purity Greater than 98%
    1.3 Milbemycin Oxime API by Application
        1.3.1 Global Milbemycin Oxime API Market Value Growth Rate Analysis by Application: 2024 VS 2031
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Other
    1.4 Global Market Growth Prospects
        1.4.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts (2020-2031)
        1.4.2 Global Milbemycin Oxime API Production Capacity Estimates and Forecasts (2020-2031)
        1.4.3 Global Milbemycin Oxime API Production Estimates and Forecasts (2020-2031)
        1.4.4 Global Milbemycin Oxime API Market Average Price Estimates and Forecasts (2020-2031)
    1.5 Assumptions and Limitations

 2 Market Competition by Manufacturers
    2.1 Global Milbemycin Oxime API Production Market Share by Manufacturers (2020-2025)
    2.2 Global Milbemycin Oxime API Production Value Market Share by Manufacturers (2020-2025)
    2.3 Global Key Players of Milbemycin Oxime API, Industry Ranking, 2023 VS 2024
    2.4 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.5 Global Milbemycin Oxime API Average Price by Manufacturers (2020-2025)
    2.6 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    2.7 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    2.8 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    2.9 Milbemycin Oxime API Market Competitive Situation and Trends
        2.9.1 Milbemycin Oxime API Market Concentration Rate
        2.9.2 Global 5 and 10 Largest Milbemycin Oxime API Players Market Share by Revenue
    2.10 Mergers & Acquisitions, Expansion

 3 Milbemycin Oxime API Production by Region
    3.1 Global Milbemycin Oxime API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
    3.2 Global Milbemycin Oxime API Production Value by Region (2020-2031)
        3.2.1 Global Milbemycin Oxime API Production Value by Region (2020-2025)
        3.2.2 Global Forecasted Production Value of Milbemycin Oxime API by Region (2026-2031)
    3.3 Global Milbemycin Oxime API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
    3.4 Global Milbemycin Oxime API Production Volume by Region (2020-2031)
        3.4.1 Global Milbemycin Oxime API Production by Region (2020-2025)
        3.4.2 Global Forecasted Production of Milbemycin Oxime API by Region (2026-2031)
    3.5 Global Milbemycin Oxime API Market Price Analysis by Region (2020-2025)
    3.6 Global Milbemycin Oxime API Production and Value, Year-over-Year Growth
        3.6.1 China Milbemycin Oxime API Production Value Estimates and Forecasts (2020-2031)

 4 Milbemycin Oxime API Consumption by Region
    4.1 Global Milbemycin Oxime API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
    4.2 Global Milbemycin Oxime API Consumption by Region (2020-2031)
        4.2.1 Global Milbemycin Oxime API Consumption by Region (2020-2025)
        4.2.2 Global Milbemycin Oxime API Forecasted Consumption by Region (2026-2031)
    4.3 North America
        4.3.1 North America Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
        4.3.2 North America Milbemycin Oxime API Consumption by Country (2020-2031)
        4.3.3 U.S.
        4.3.4 Canada
    4.4 Europe
        4.4.1 Europe Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
        4.4.2 Europe Milbemycin Oxime API Consumption by Country (2020-2031)
        4.4.3 Germany
        4.4.4 France
        4.4.5 U.K.
        4.4.6 Italy
        4.4.7 Russia
    4.5 Asia Pacific
        4.5.1 Asia Pacific Milbemycin Oxime API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
        4.5.2 Asia Pacific Milbemycin Oxime API Consumption by Region (2020-2031)
        4.5.3 China
        4.5.4 Japan
        4.5.5 South Korea
        4.5.6 China Taiwan
        4.5.7 Southeast Asia
        4.5.8 India
    4.6 Latin America, Middle East & Africa
        4.6.1 Latin America, Middle East & Africa Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
        4.6.2 Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2020-2031)
        4.6.3 Mexico
        4.6.4 Brazil
        4.6.5 Turkey
        4.6.6 GCC Countries

 5 Segment by Type
    5.1 Global Milbemycin Oxime API Production by Type (2020-2031)
        5.1.1 Global Milbemycin Oxime API Production by Type (2020-2025)
        5.1.2 Global Milbemycin Oxime API Production by Type (2026-2031)
        5.1.3 Global Milbemycin Oxime API Production Market Share by Type (2020-2031)
    5.2 Global Milbemycin Oxime API Production Value by Type (2020-2031)
        5.2.1 Global Milbemycin Oxime API Production Value by Type (2020-2025)
        5.2.2 Global Milbemycin Oxime API Production Value by Type (2026-2031)
        5.2.3 Global Milbemycin Oxime API Production Value Market Share by Type (2020-2031)
    5.3 Global Milbemycin Oxime API Price by Type (2020-2031)

 6 Segment by Application
    6.1 Global Milbemycin Oxime API Production by Application (2020-2031)
        6.1.1 Global Milbemycin Oxime API Production by Application (2020-2025)
        6.1.2 Global Milbemycin Oxime API Production by Application (2026-2031)
        6.1.3 Global Milbemycin Oxime API Production Market Share by Application (2020-2031)
    6.2 Global Milbemycin Oxime API Production Value by Application (2020-2031)
        6.2.1 Global Milbemycin Oxime API Production Value by Application (2020-2025)
        6.2.2 Global Milbemycin Oxime API Production Value by Application (2026-2031)
        6.2.3 Global Milbemycin Oxime API Production Value Market Share by Application (2020-2031)
    6.3 Global Milbemycin Oxime API Price by Application (2020-2031)

 7 Key Companies Profiled
    7.1 Livzon Pharmaceutical Group Inc
        7.1.1 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Company Information
        7.1.2 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Portfolio
        7.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Production, Value, Price and Gross Margin (2020-2025)
        7.1.4 Livzon Pharmaceutical Group Inc Main Business and Markets Served
        7.1.5 Livzon Pharmaceutical Group Inc Recent Developments/Updates
    7.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        7.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Company Information
        7.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Portfolio
        7.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2020-2025)
        7.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Main Business and Markets Served
        7.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
    7.3 Hubei Honch Pharmaceutical Co.,Ltd
        7.3.1 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Company Information
        7.3.2 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Portfolio
        7.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Production, Value, Price and Gross Margin (2020-2025)
        7.3.4 Hubei Honch Pharmaceutical Co.,Ltd Main Business and Markets Served
        7.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
    7.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        7.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Company Information
        7.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Portfolio
        7.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Production, Value, Price and Gross Margin (2020-2025)
        7.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Main Business and Markets Served
        7.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates

 8 Industry Chain and Sales Channels Analysis
    8.1 Milbemycin Oxime API Industry Chain Analysis
    8.2 Milbemycin Oxime API Raw Material Supply Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
    8.3 Milbemycin Oxime API Production Mode & Process Analysis
    8.4 Milbemycin Oxime API Sales and Marketing
        8.4.1 Milbemycin Oxime API Sales Channels
        8.4.2 Milbemycin Oxime API Distributors
    8.5 Milbemycin Oxime API Customer Analysis

 9 Milbemycin Oxime API Market Dynamics
    9.1 Milbemycin Oxime API Industry Trends
    9.2 Milbemycin Oxime API Market Drivers
    9.3 Milbemycin Oxime API Market Challenges
    9.4 Milbemycin Oxime API Market Restraints

 10 Research Findings and Conclusion

 11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Author List
    11.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Milbemycin Oxime API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Milbemycin Oxime API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Milbemycin Oxime API Production Capacity (KG) by Manufacturers in 2024
 Table 4. Global Milbemycin Oxime API Production by Manufacturers (2020-2025) & (KG)
 Table 5. Global Milbemycin Oxime API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Milbemycin Oxime API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Milbemycin Oxime API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Milbemycin Oxime API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Milbemycin Oxime API as of 2024)
 Table 10. Global Market Milbemycin Oxime API Average Price by Manufacturers (US$/KG) & (2020-2025)
 Table 11. Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
 Table 13. Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
 Table 14. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Milbemycin Oxime API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Milbemycin Oxime API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Milbemycin Oxime API Production Value Market Share by Region (2020-2025)
 Table 19. Global Milbemycin Oxime API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Milbemycin Oxime API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Milbemycin Oxime API Production Comparison by Region: 2020 VS 2024 VS 2031 (KG)
 Table 22. Global Milbemycin Oxime API Production (KG) by Region (2020-2025)
 Table 23. Global Milbemycin Oxime API Production Market Share by Region (2020-2025)
 Table 24. Global Milbemycin Oxime API Production (KG) Forecast by Region (2026-2031)
 Table 25. Global Milbemycin Oxime API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Milbemycin Oxime API Market Average Price (US$/KG) by Region (2020-2025)
 Table 27. Global Milbemycin Oxime API Market Average Price (US$/KG) by Region (2026-2031)
 Table 28. Global Milbemycin Oxime API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (KG)
 Table 29. Global Milbemycin Oxime API Consumption by Region (2020-2025) & (KG)
 Table 30. Global Milbemycin Oxime API Consumption Market Share by Region (2020-2025)
 Table 31. Global Milbemycin Oxime API Forecasted Consumption by Region (2026-2031) & (KG)
 Table 32. Global Milbemycin Oxime API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (KG)
 Table 34. North America Milbemycin Oxime API Consumption by Country (2020-2025) & (KG)
 Table 35. North America Milbemycin Oxime API Consumption by Country (2026-2031) & (KG)
 Table 36. Europe Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (KG)
 Table 37. Europe Milbemycin Oxime API Consumption by Country (2020-2025) & (KG)
 Table 38. Europe Milbemycin Oxime API Consumption by Country (2026-2031) & (KG)
 Table 39. Asia Pacific Milbemycin Oxime API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (KG)
 Table 40. Asia Pacific Milbemycin Oxime API Consumption by Region (2020-2025) & (KG)
 Table 41. Asia Pacific Milbemycin Oxime API Consumption by Region (2026-2031) & (KG)
 Table 42. Latin America, Middle East & Africa Milbemycin Oxime API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (KG)
 Table 43. Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2020-2025) & (KG)
 Table 44. Latin America, Middle East & Africa Milbemycin Oxime API Consumption by Country (2026-2031) & (KG)
 Table 45. Global Milbemycin Oxime API Production (KG) by Type (2020-2025)
 Table 46. Global Milbemycin Oxime API Production (KG) by Type (2026-2031)
 Table 47. Global Milbemycin Oxime API Production Market Share by Type (2020-2025)
 Table 48. Global Milbemycin Oxime API Production Market Share by Type (2026-2031)
 Table 49. Global Milbemycin Oxime API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Milbemycin Oxime API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Milbemycin Oxime API Production Value Market Share by Type (2020-2025)
 Table 52. Global Milbemycin Oxime API Production Value Market Share by Type (2026-2031)
 Table 53. Global Milbemycin Oxime API Price (US$/KG) by Type (2020-2025)
 Table 54. Global Milbemycin Oxime API Price (US$/KG) by Type (2026-2031)
 Table 55. Global Milbemycin Oxime API Production (KG) by Application (2020-2025)
 Table 56. Global Milbemycin Oxime API Production (KG) by Application (2026-2031)
 Table 57. Global Milbemycin Oxime API Production Market Share by Application (2020-2025)
 Table 58. Global Milbemycin Oxime API Production Market Share by Application (2026-2031)
 Table 59. Global Milbemycin Oxime API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Milbemycin Oxime API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Milbemycin Oxime API Production Value Market Share by Application (2020-2025)
 Table 62. Global Milbemycin Oxime API Production Value Market Share by Application (2026-2031)
 Table 63. Global Milbemycin Oxime API Price (US$/KG) by Application (2020-2025)
 Table 64. Global Milbemycin Oxime API Price (US$/KG) by Application (2026-2031)
 Table 65. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Company Information
 Table 66. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Specification and Application
 Table 67. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 68. Livzon Pharmaceutical Group Inc Main Business and Markets Served
 Table 69. Livzon Pharmaceutical Group Inc Recent Developments/Updates
 Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Company Information
 Table 71. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Specification and Application
 Table 72. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 73. Zhejiang Hisun Pharmaceutical Co., Ltd Main Business and Markets Served
 Table 74. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 75. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Company Information
 Table 76. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Specification and Application
 Table 77. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 78. Hubei Honch Pharmaceutical Co.,Ltd Main Business and Markets Served
 Table 79. Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
 Table 80. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Company Information
 Table 81. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Specification and Application
 Table 82. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Production (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 83. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Main Business and Markets Served
 Table 84. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Milbemycin Oxime API Distributors List
 Table 88. Milbemycin Oxime API Customers List
 Table 89. Milbemycin Oxime API Market Trends
 Table 90. Milbemycin Oxime API Market Drivers
 Table 91. Milbemycin Oxime API Market Challenges
 Table 92. Milbemycin Oxime API Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Milbemycin Oxime API
 Figure 2. Global Milbemycin Oxime API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Milbemycin Oxime API Market Share by Type: 2024 VS 2031
 Figure 4. 98% Purity Product Picture
 Figure 5. Purity Greater than 98% Product Picture
 Figure 6. Global Milbemycin Oxime API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Milbemycin Oxime API Market Share by Application: 2024 VS 2031
 Figure 8. Dog
 Figure 9. Cat
 Figure 10. Other
 Figure 11. Global Milbemycin Oxime API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Milbemycin Oxime API Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Milbemycin Oxime API Production Capacity (KG) & (2020-2031)
 Figure 14. Global Milbemycin Oxime API Production (KG) & (2020-2031)
 Figure 15. Global Milbemycin Oxime API Average Price (US$/KG) & (2020-2031)
 Figure 16. Milbemycin Oxime API Report Years Considered
 Figure 17. Milbemycin Oxime API Production Share by Manufacturers in 2024
 Figure 18. Global Milbemycin Oxime API Production Value Share by Manufacturers (2024)
 Figure 19. Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Milbemycin Oxime API Revenue in 2024
 Figure 21. Global Milbemycin Oxime API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Milbemycin Oxime API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Milbemycin Oxime API Production Comparison by Region: 2020 VS 2024 VS 2031 (KG)
 Figure 24. Global Milbemycin Oxime API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. China Milbemycin Oxime API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Global Milbemycin Oxime API Consumption by Region: 2020 VS 2024 VS 2031 (KG)
 Figure 27. Global Milbemycin Oxime API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 28. North America Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 29. North America Milbemycin Oxime API Consumption Market Share by Country (2020-2031)
 Figure 30. U.S. Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 31. Canada Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 32. Europe Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 33. Europe Milbemycin Oxime API Consumption Market Share by Country (2020-2031)
 Figure 34. Germany Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 35. France Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 36. U.K. Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 37. Italy Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 38. Russia Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 39. Asia Pacific Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 40. Asia Pacific Milbemycin Oxime API Consumption Market Share by Region (2020-2031)
 Figure 41. China Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 42. Japan Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 43. South Korea Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 44. China Taiwan Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 45. Southeast Asia Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 46. India Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 47. Latin America, Middle East & Africa Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 48. Latin America, Middle East & Africa Milbemycin Oxime API Consumption Market Share by Country (2020-2031)
 Figure 49. Mexico Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 50. Brazil Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 51. Turkey Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 52. GCC Countries Milbemycin Oxime API Consumption and Growth Rate (2020-2031) & (KG)
 Figure 53. Global Production Market Share of Milbemycin Oxime API by Type (2020-2031)
 Figure 54. Global Production Value Market Share of Milbemycin Oxime API by Type (2020-2031)
 Figure 55. Global Milbemycin Oxime API Price (US$/KG) by Type (2020-2031)
 Figure 56. Global Production Market Share of Milbemycin Oxime API by Application (2020-2031)
 Figure 57. Global Production Value Market Share of Milbemycin Oxime API by Application (2020-2031)
 Figure 58. Global Milbemycin Oxime API Price (US$/KG) by Application (2020-2031)
 Figure 59. Milbemycin Oxime API Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation

Description

The global market for Milbemycin Oxime API was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite"s nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Market Segmentation